| AASLD

Home

Micro‐elimination of Hepatitis C in Low‐ and Middle‐Income Settings: Challenges and Windows of Opportunity

Read more about Micro‐elimination of Hepatitis C in Low‐ and Middle‐Income Settings: Challenges and Windows of Opportunity

Enrique Wolpert Barraza, David Kershenobich Stalnikowitz, Jorge Enrique Guerrero Guerrero, Alethse Torre Rosas – 9 August 2021

PRO: Liver Transplantation in the Times of COVID‐19: Patients with COVID‐19 Infection Should Undergo Liver Transplantation

Read more about PRO: Liver Transplantation in the Times of COVID‐19: Patients with COVID‐19 Infection Should Undergo Liver Transplantation

Ashley M. Nickerson, Lindsay A. Sobotka, Sean G. Kelly – 9 August 2021

Breastfeeding to Prevent NAFLD

Read more about Breastfeeding to Prevent NAFLD

George Boon‐Bee Goh, Wah Kheong Chan, Vincent Wai‐Sun Wong – 8 August 2021

Issue Information ‐ Instructions to Authors

Read more about Issue Information ‐ Instructions to Authors

8 August 2021

Liver Transplantation for Acute Liver Injury in Asians Is More Likely Due to Herbal and Dietary Supplements

Read more about Liver Transplantation for Acute Liver Injury in Asians Is More Likely Due to Herbal and Dietary Supplements

Varun Kesar, Lindsey Channen, Umair Masood, Priya Grewal, Jawad Ahmad, Nitzan C. Roth, Joseph A. Odin – 8 August 2021 – Drug‐induced liver injury (DILI) due to medications and herbal and dietary supplements (HDSs) is a major cause of acute liver injury leading to liver transplantation (LT). This study used United Network for Organ Sharing LT data to analyze severe HDS‐induced acute liver injury in the United States.